These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 15984139)

  • 1. The dogged scientist, the old lab vial, and the quest to stop cancer.
    Stipp D
    Fortune; 2005 Jun; 151(13):175-6, 178-80, 182, passim. PubMed ID: 15984139
    [No Abstract]   [Full Text] [Related]  

  • 2. Biopharmaceutical benchmarks--2003.
    Walsh G
    Nat Biotechnol; 2003 Aug; 21(8):865-70. PubMed ID: 12894198
    [No Abstract]   [Full Text] [Related]  

  • 3. The second wave in kinase cancer drugs.
    Garber K
    Nat Biotechnol; 2006 Feb; 24(2):127-30. PubMed ID: 16465146
    [No Abstract]   [Full Text] [Related]  

  • 4. Roche consolidates grip on anti-angiogenesis market.
    Moran N
    Nat Biotechnol; 2008 Oct; 26(10):1055-6. PubMed ID: 18846054
    [No Abstract]   [Full Text] [Related]  

  • 5. Biopharma deal-making in 2016.
    Micklus A; Muntner S
    Nat Rev Drug Discov; 2017 Mar; 16(3):161-162. PubMed ID: 28209988
    [No Abstract]   [Full Text] [Related]  

  • 6. A perfect storm for innovation.
    Williams RN
    Clin Pharmacol Ther; 2010 Jul; 88(1):23; author reply 23-4. PubMed ID: 20445532
    [No Abstract]   [Full Text] [Related]  

  • 7. Biopharma in Piedmont, Italy.
    Sakariassen KS
    Nat Rev Drug Discov; 2005 Jun; 4(6):519. PubMed ID: 15959953
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial: biopharmaceutical technologies.
    Jungbauer A
    Biotechnol J; 2007 Jun; 2(6):647. PubMed ID: 17570696
    [No Abstract]   [Full Text] [Related]  

  • 9. The farmyard drug store.
    Nature; 2006 Sep; 443(7107):16-7. PubMed ID: 16957702
    [No Abstract]   [Full Text] [Related]  

  • 10. Russia through the prism of the world biopharmaceutical market.
    Bairamashvili DI; Rabinovich ML
    Biotechnol J; 2007 Jul; 2(7):801-17. PubMed ID: 17615600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dose of reality for rational therapies.
    Nat Biotechnol; 2005 Mar; 23(3):267. PubMed ID: 15765066
    [No Abstract]   [Full Text] [Related]  

  • 12. The other path for follow-ons.
    Nat Biotechnol; 2008 Jul; 26(7):715. PubMed ID: 18612272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New biopharmaceuticals in the USA: trends in development and marketing approvals 1995-1999.
    Reichert JM
    Trends Biotechnol; 2000 Sep; 18(9):364-9. PubMed ID: 10942959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New frontiers in cancer treatment].
    Tortora G; Daniele G
    Recenti Prog Med; 2006 Dec; 97(12):781-6. PubMed ID: 17252737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biopharmaceuticals: recent approvals and likely directions.
    Walsh G
    Trends Biotechnol; 2005 Nov; 23(11):553-8. PubMed ID: 16051388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating investment in biopharmaceutical R&D.
    Carter PH; Berndt ER; DiMasi JA; Trusheim M
    Nat Rev Drug Discov; 2016 Oct; 15(10):673-4. PubMed ID: 27616295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I dose escalation study of telatinib, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor 2 and 3, platelet-derived growth factor receptor beta, and c-Kit, in patients with advanced or metastatic solid tumors.
    Eskens FA; Steeghs N; Verweij J; Bloem JL; Christensen O; van Doorn L; Ouwerkerk J; de Jonge MJ; Nortier JW; Kraetzschmar J; Rajagopalan P; Gelderblom H
    J Clin Oncol; 2009 Sep; 27(25):4169-76. PubMed ID: 19636022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGF-targeted therapy: mechanisms of anti-tumour activity.
    Ellis LM; Hicklin DJ
    Nat Rev Cancer; 2008 Aug; 8(8):579-91. PubMed ID: 18596824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibition of the VEGF receptor system with tyrosine kinase inhibitors. Angiogenesis inhibition in oncology].
    Mross K
    Pharm Unserer Zeit; 2008; 37(5):404-15. PubMed ID: 18729270
    [No Abstract]   [Full Text] [Related]  

  • 20. Mobile economics and pricing of health care services.
    Huttin CC
    Technol Health Care; 2012; 20(5):459-61. PubMed ID: 23079949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.